This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Institut National De La Santé Et De La Recherche Médicale (Inserm), Sorbonne Université. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 331 
1 out of 19 
1 out of 266 Years Active: 2026
Title: Vlad Ratziu and Research on Non-Alcoholic Fatty Liver Disease.
Introduction
Vlad Ratziu is an inventor based in Servon, France, whose patent work concerns compounds for preventing or treating non-alcoholic fatty liver disease (NAFLD). His research focus includes hepatic steatosis and non-alcoholic steatohepatitis (NASH).
Latest Patents
Ratziu is associated with 1 patent: “Compounds for use (in particular RIPA-56) in the prevention and/or treatment of non-alcoholic fatty liver disease.” The invention describes compounds and compositions intended for use in preventing or treating NAFLD, including hepatic steatosis and NASH.
Career Highlights
Ratziu has worked with the French National Institute of Health and Medical Research (Inserm) and Assistance Publique–Hôpitaux de Paris. His patent reflects research into potential therapeutic approaches for liver disease.
Collaborations
His listed coworker is Jérémie Gautheron. His work connects research in liver disease with institutions involved in health and medical research.
Conclusion
Vlad Ratziu’s patent activity centers on compounds such as RIPA-56 and their potential use in preventing or treating NAFLD, hepatic steatosis, and NASH.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile